Tag: generic drugs
Cost-Effectiveness Analysis: Measuring the Value of Generic Drugs
Cost-effectiveness analysis reveals how generic drugs save billions by delivering the same health outcomes at a fraction of the cost. Learn how pricing, competition, and smart substitution drive real savings in healthcare.
Read More
Long-Term Safety of Generic vs Brand Drugs: What the Data Really Shows
Long-term studies show generics are generally safe, but for certain drugs and patients, small differences in manufacturing can lead to serious health risks. Here's what the data really says about brand vs generic safety over time.
Read More
Why Generic Drugs Look Different from Brand-Name Medicines
Generic drugs look different from brand-name medicines due to U.S. trademark laws, not because they're less effective. Learn why the color, shape, and size change - and why it doesn't affect how they work.
Read More
Patent Law and Generics: How Patents Protect Innovation in Pharmaceuticals
Patent law protects pharmaceutical innovation by giving companies exclusive rights to sell new drugs, but the Hatch-Waxman Act ensures generics can enter the market fairly. This balance saves billions and keeps medicines affordable.
Read More